{
    "title": "GlaxoSmithKline puts 'for sale' sign on drink brands Lucozade and Ribena",
    "url": "https://www.dailymail.co.uk/money/markets/article-2314316/GlaxoSmithKline-puts-sale-sign-drink-brands-Lucozade-Ribena.html",
    "date": "2013-04-24",
    "keywords": [
        "cent",
        "sale",
        "glaxosmithkline",
        "review",
        "quarter",
        "pipeline",
        "soriot",
        "meeting",
        "sign",
        "drink",
        "mail",
        "gmt",
        "april",
        "view",
        "lucozade",
        "ribena",
        "business",
        "divisionthe",
        "equity",
        "yesterday",
        "fall",
        "operating",
        "profit",
        "executive",
        "sir",
        "management",
        "progress",
        "increase",
        "dividend",
        "collapse",
        "lloyds",
        "branch",
        "blow",
        "street",
        "competition",
        "division",
        "zantac",
        "tagamet",
        "stomach",
        "acid",
        "antinausea",
        "treatment",
        "zofran",
        "gsk",
        "company",
        "analyst",
        "andrew",
        "baum",
        "citigroup",
        "focus",
        "boss",
        "thursday",
        "criticism",
        "authority",
        "pension",
        "fund",
        "forum",
        "pay",
        "package",
        "lapff",
        "firm"
    ],
    "category": [
        "money",
        "markets"
    ]
}